Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness.

MLA

Kesselheim, Aaron, et al. “Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness.” Drug Safety, vol. 38, no. 10, Oct. 2015, pp. 849–53. EBSCOhost, https://doi.org/10.1007/s40264-015-0315-7.

APA

Kesselheim, A., Gagne, J., Kesselheim, A. S., & Gagne, J. J. (2015). Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness. Drug Safety, 38(10), 849–853. https://doi.org/10.1007/s40264-015-0315-7

Chicago

Kesselheim, Aaron, Joshua Gagne, Aaron S Kesselheim, and Joshua J Gagne. 2015. “Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness.” Drug Safety 38 (10): 849–53. doi:10.1007/s40264-015-0315-7.